Boston Scientific Corporation’s $4.2 Billion Acquisition of BTG

Barclays and Shearman & Sterling are acting as financial and legal advisors, respectively, on behalf of Boston Scientific. Boston Scientific (NYSE: BSX) has reached an agreement…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here